A phase II trial of BGB 324 in patients with acute myeloid leukaemia
Latest Information Update: 25 May 2018
At a glance
- Drugs Bemcentinib (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors BerGenBio
- 18 May 2018 According to a media release, interim data from this study will be presented at the 23rd Congress of the European Hematology Association (EHA).
- 27 Mar 2017 New trial record